Using Nano-Modified Virus Crispr/Cas9 to Overcome Egfr-Tki Resistance in Nsclc (II) = 利用奈米修飾病毒CRISPR/Cas9技術克服非小細胞肺癌EGFR標靶治療之抗藥性 (II)

Project title

利用奈米修飾病毒CRISPR/Cas9技術克服非小細胞肺癌EGFR標靶治療之抗藥性 (II)

Internal ID

MOST110-2124-M002-010

Principal Investigator

Start Date

August 1, 2021

End Date

July 31, 2022

Organizations

Internal Medicine

Partner Organizations

National Science and Technology Council